Metastatic Urothelial Cancer Recruiting Phase 2 / 3 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0066157 (Metastatic Urothelial Cancer)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06225596Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)Treatment